Skip to main content

Mckesson Corp(MCK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low836.62
Day High858.00
Open:858.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), McKesson (MCK) and Regeneron (REGN)
Tipranks
Wells Fargo Releases a Hold Rating on McKesson (MCK)
Tipranks
McKesson Secures New $2 Billion Senior Credit Facilities
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), Eli Lilly & Co (LLY)
Zacks Investment Research
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
StockStory
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack
MCK
Zacks Investment Research
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
Zacks Investment Research
Here's Why You Should Add McKesson Stock to Your Portfolio Now
Here's Why You Should Add McKesson Stock to Your Portfolio Now
Tipranks
McKesson (MCK) Receives a Buy from Barclays
The Globe and Mail
13 U.S. health care stocks to consider in uncertain markets
For Number Cruncher column in Globe Investor/ROB only.
MarketBeat
3 Stocks That Could Be Next to Announce a Stock Split
MarketBeat.com
Zacks Investment Research
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
StockStory
1 Growth Stock Set to Flourishand 2 We Find Risky
SEMR
Zacks Investment Research
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
McKesson Affirms Fiscal 2026 Outlook, Sets Earnings Date
Tipranks
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), McKesson (MCK) and Cybin (HELP)
Tipranks
Bank of America Securities Sticks to Its Buy Rating for McKesson (MCK)
MarketBeat
3 Dividend Growth Stocks Quietly Raising Payouts
MarketBeat.com
StockStory
2 S&P 500 Stocks to Consider Right Now and 1 We Turn Down
ALLE
StockStory
3 Reasons We’re Fans of McKesson (MCK)
MCK
Zacks Investment Research
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Tipranks
Deutsche Bank Remains a Buy on McKesson (MCK)
StockStory
3 Market-Beating Stocks for Long-Term Investors
MTSI
StockStory
2 Surging Stocks to Own for Decades and 1 We Find Risky
MEC
StockStory
2 Momentum Stocks Worth Your Attention and 1 We Ignore
MPWR
Zacks Investment Research
Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?
Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?
StockStory
5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call
MCK
Tipranks
Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Biogen (BIIB)
Tipranks
McKesson Earnings Call Highlights Specialty and Tech Strength
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY)
Tipranks
Wells Fargo Remains a Hold on McKesson (MCK)

Profile

McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.